GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (NEOE:CBST) » Definitions » Capex-to-Revenue

Cannabist Company Holdings (NEOE:CBST) Capex-to-Revenue : 0.01 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Cannabist Company Holdings's Capital Expenditure for the three months ended in Sep. 2024 was C$-2.06 Mil. Its Revenue for the three months ended in Sep. 2024 was C$155.49 Mil.

Hence, Cannabist Company Holdings's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.01.


Cannabist Company Holdings Capex-to-Revenue Historical Data

The historical data trend for Cannabist Company Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings Capex-to-Revenue Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial 1.00 0.24 0.26 0.14 0.02

Cannabist Company Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.01 0.01 0.01

Competitive Comparison of Cannabist Company Holdings's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's Capex-to-Revenue falls into.



Cannabist Company Holdings Capex-to-Revenue Calculation

Cannabist Company Holdings's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-13.37) / 685.996
=0.02

Cannabist Company Holdings's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.056) / 155.485
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings  (NEOE:CBST) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Cannabist Company Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under ClaraCeed, Seed & Starin, and Triple 777 brands among others.
Executives
David Sirolly Senior Officer
Julie Anne Hill Director
Jesse Channon Senior Officer
David Hart Senior Officer
Derek Alan Watson Senior Officer
Jeffrey James Clarke Director
Alison Worthington Director
Nicholas Keane Vita 10% Security Holder, Director
Bryan Lamont Olson Senior Officer
Michael James Abbott 10% Security Holder, Director

Cannabist Company Holdings Headlines

No Headlines